Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2020

01-12-2020 | Osteoporosis | Research article

Association of IL-6 174G/C (rs1800795) and 572C/G (rs1800796) polymorphisms with risk of osteoporosis: a meta-analysis

Authors: Bin Chen, Hong-zhuo Li

Published in: BMC Musculoskeletal Disorders | Issue 1/2020

Login to get access

Abstract

Background

Several studies have been performed to investigate association between IL-6 174G/C (rs1800795) and 572C/G (rs1800796) gene polymorphisms and osteoporosis predisposition. However, the results were conflicting. So, we performed a meta-analysis designed to provide more reliable results for the association between IL-6 gene polymorphisms and osteoporosis.

Methods

Studies were searched using PubMed, EMBASE, the Cochrane Library and Wanfang electronic databases. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the association between IL-6 174G/C (rs1800795) and 572C/G (rs1800796) gene polymorphisms and osteoporosis risk. The false-positive report probabilities (FPRP) test and the venice criteria were used to assess the credibility of statistically significant associations.

Results

A total of 9 studies with 1891 osteoporosis patients and 2027 healthy controls were included in current meta-analysis. Overall, The IL-6 174G/C (rs1800795) gene polymorphism was insignificantly associated with osteoporosis vulnerability. For IL-6 572C/G (rs1800796), statistically significant elevated osteoporosis vulnerability was found in IL-6 572C/G additive model (OR = 2.25, 95% CI: 1.55–3.26), dominant model (OR = 1.42, 95% CI: 0.78–2.56) and recessive model (OR = 1.96, 95% CI: 1.36–2.83). However, the IL-6 572C/G C allele was found to be associated with reduced susceptibility to osteoporosis (OR = 0.76, 95% CI: 0.56–1.04). When excluding studies that did not conform to HWE, the results did not change significantly. Further, when we evaluated the credibility of the positive results of the current meta-analysis, we identified less credible positive results in IL-6 572C/G recessive and additive model.

Conclusion

In conclusion, IL-6 572C/G GG genotype may be associated with increased risk of osteoporosis.
Literature
1.
2.
Wiktorowicz ME, et al. Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int. 2001;12(4):271–8.PubMedCrossRef
3.
Havill LM, et al. Effects of genes, sex, age, and activity on BMC, bone size, and areal and volumetric BMD. J Bone Miner Res. 2007;22(5):737–46.PubMedCrossRef
4.
5.
6.
Bandres E, et al. Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women. J Endocrinol Investig. 2005;28(4):312–21.CrossRef
7.
Mosaad YM, et al. Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis. Hum Immunol. 2014;75(5):452–61.PubMedCrossRef
8.
Nordstrom A, et al. Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women. Osteoporos Int. 2004;15(10):820–6.PubMedCrossRef
9.
Kishimoto T, et al. The molecular biology of interleukin 6 and its receptor. CIBA Found Symp. 1992;167:5–16 discussion 16-23.PubMed
10.
Ishimi Y, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990;145(10):3297–303.PubMed
11.
Littlewood AJ, et al. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology. 1991;129(3):1513–20.PubMedCrossRef
12.
Ralston SH. Do genetic markers aid in risk assessment? Osteoporos Int. 1998;8(Suppl 1):S37–42.PubMed
13.
14.
Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275(24):18138–44.PubMedCrossRef
15.
Fishman D, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic- onset juvenile chronic arthritis. J Clin Investig. 1998;102(7):1369–76.PubMedCrossRefPubMedCentral
16.
Ferrari SL, et al. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum. 2001;44(1):196–201.PubMedCrossRef
17.
Ji YF, et al. Impact of interleukin-6 gene polymorphisms and its interaction with obesity on osteoporosis risk in Chinese postmenopausal women. Environ Health Prev Med. 2019;24(1):48.PubMedPubMedCentralCrossRef
18.
Magana JJ, et al. Association of interleukin-6 gene polymorphisms with bone mineral density in Mexican women. Arch Med Res. 2008;39(6):618–24.PubMedCrossRef
19.
20.
21.
Thakkinstian A, et al. Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol. 2011;173(12):1365–79.PubMedCrossRef
22.
23.
24.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.PubMed
25.
Klug SJ, et al. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 2009;10(8):772–84.PubMedCrossRef
26.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.PubMedCrossRef
27.
28.
Wacholder S, et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96(6):434–42.PubMedCrossRefPubMedCentral
29.
Ioannidis JP, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37(1):120–32.PubMedCrossRef
30.
Eftekhari H, et al. Association of interleukin-6 (rs1800796) but not transforming growth factor beta 1 (rs1800469) with serum calcium levels in osteoporotic patients. Gene. 2018;671:21–7.PubMedCrossRef
31.
Deveci D, Ozkan ZS, Yuce H. Is there any relation between IL-6 gene −174 G>C polymorphism and postmenopausal osteoporosis? Eur J Obstet Gynecol Reprod Biol. 2012;164(1):98–101.PubMedCrossRef
32.
Czerny B, et al. The association of IL-1beta, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2010;149(1):82–5.PubMedCrossRef
33.
Breuil V, et al. Gene polymorphisms and osteoporotic fractures: a study in postmenopausal French women. Joint Bone Spine. 2009;76(3):317–9.PubMedCrossRef
34.
Dincel E, et al. Hip fracture risk and different gene polymorphisms in the Turkish population. Clinics (Sao Paulo). 2008;63(5):645–50.
35.
Kusek J, et al. The influence of interleukin-6 and tumor necrosis factor α gene polymorphisms on bone mineral density in postmenopausal women. Ginekol Pol. 2008;79(6):426–31.PubMed
36.
Montazeri, Z., et al., Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer. Gut, 2019: p. gutjnl-2019-319313.
37.
Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56(4):297–303.PubMedCrossRef
38.
Ioannidis JPA, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37(1):120–32.PubMedCrossRef
39.
Ni Y, et al. Association of IL-6 G-174C polymorphism with bone mineral density. J Bone Miner Metab. 2014;32(2):167–73.PubMedCrossRef
40.
Fajar, J.K. and A. Azharuddin, The association between interleukin 6–174 G/C gene polymorphism and the risk of osteoporosis: A meta-analysis. J Taibah Univ Med Sci, 2017. 12(3): p. 212–220.PubMedCrossRef
41.
Garnero P, et al. Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study. Bone. 2002;31(1):43–50.PubMedCrossRef
42.
Ferrari SL, et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham osteoporosis study. J Bone Miner Res. 2004;19(4):552–9.PubMedCrossRef
43.
Moffett SP, et al. Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res. 2004;19(10):1612–8.PubMedCrossRef
44.
45.
Lee JS, Suh KT, Eun IS. Polymorphism in interleukin-6 gene is associated with bone mineral density in patients with adolescent idiopathic scoliosis. J Bone Joint Surg Br. 2010;92(8):1118–22.PubMedCrossRef
46.
Mendez JP, et al. Impact of genetic variants of IL-6, IL6R, LRP5, ESR1 and SP7 genes on bone mineral density in postmenopausal Mexican-mestizo women with obesity. Gene. 2013;528(2):216–20.PubMedCrossRef
Metadata
Title
Association of IL-6 174G/C (rs1800795) and 572C/G (rs1800796) polymorphisms with risk of osteoporosis: a meta-analysis
Authors
Bin Chen
Hong-zhuo Li
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2020
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-020-03334-x

Other articles of this Issue 1/2020

BMC Musculoskeletal Disorders 1/2020 Go to the issue

Research article

My joint pain, a web-based resource, effects on education and quality of care at 24 months

Research article

Risk of tuberculosis in patients with spondyloarthritis: data from a centralized electronic database in Hong Kong

Research article

Validity of the self-reported five-part questionnaire as an assessment of generalized joint hypermobility in early pregnancy

Research article

LncRNA SNHG9 is downregulated in osteoarthritis and inhibits chondrocyte apoptosis by downregulating miR-34a through methylation

Research article

Comparison of clinical results of anteromedial and transtibial femoral tunnel drilling in ACL reconstruction

Research article

The application of lateral-rectus approach on toddlers’ unstable pelvic fractures